SRNE Insider Trading Activity and SEC Form 4 Filings
SRNE insider trading summary
No open-market insider purchases or sales of Sorrento Therapeutics, Inc. (SRNE) have been reported on SEC Form 4 in the past 12 months.
Latest SRNE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 7, 2022 | Henry Ji | See Remarks | Buy | $179K (88,888 @ $2.02) |
| Sep 6, 2022 | Henry Ji | See Remarks | Buy | $109K (55,555 @ $1.96) |
| Aug 26, 2022 | Henry Ji | See Remarks | Buy | $70K (33,333 @ $2.11) |
| Aug 25, 2022 | Henry Ji | See Remarks | Buy | $46K (22,222 @ $2.06) |
| Jun 14, 2022 | Henry Ji | See Remarks | Buy | $14K (10,000 @ $1.40) |
| Dec 27, 2021 | Kim Janda | Director | Sell | $18K (3,000 @ $5.88) |
| Sep 27, 2021 | Kim Janda | Director | Sell | $340K (42,357 @ $8.02) |
| Sep 13, 2021 | Kim Janda | Director | Sell | $64K (8,000 @ $8.04) |
| Apr 12, 2021 | Kim Janda | Director | Sell | $13K (1,900 @ $6.97) |
| Dec 16, 2020 | Dorman Followwill | Director | Sell | $7K (1,000 @ $7.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.